Aristotle Capital Boston LLC decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 10.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 741,733 shares of the company’s stock after selling 84,529 shares during the quarter. Aristotle Capital Boston LLC owned approximately 0.80% of Acadia Healthcare worth $29,410,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in ACHC. Tidal Investments LLC raised its stake in Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 340 shares in the last quarter. Franklin Resources Inc. raised its holdings in Acadia Healthcare by 273.1% in the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company’s stock worth $6,673,000 after purchasing an additional 77,027 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock valued at $41,653,000 after buying an additional 13,368 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 259.6% in the 4th quarter. GAMMA Investing LLC now owns 2,384 shares of the company’s stock worth $95,000 after buying an additional 1,721 shares during the last quarter.
Acadia Healthcare Stock Up 2.3 %
Shares of NASDAQ ACHC opened at $23.31 on Friday. The stock has a market cap of $2.15 billion, a PE ratio of 7.64, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a 50-day moving average of $27.61 and a 200 day moving average of $37.59. Acadia Healthcare Company, Inc. has a 12-month low of $20.36 and a 12-month high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Acadia Healthcare
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
- Five stocks we like better than Acadia Healthcare
- How to Effectively Use the MarketBeat Ratings Screener
- MarketBeat Week in Review – 04/28 – 05/02
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Meta Takes A Bow With Q1 Earnings – Watch For Tariff Impact in Q2
- About the Markup Calculator
- Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.